not tagged
not tagged
['breast']
at #esmo22 final results of #data trial on extended endocrine therapy (3 vs. 6 yrs of ai after 2-3yrs of tam in post menopausal hr+,her2-neg #breastcancer): after 10 yrs f-u, no significant difference in adfs nor in aos. benefit observed in the subgroup of n+ patients 
MD, Medical Oncologist????•Research Fellow at @JulesBordet Institute in Brussels???? Great interest in #BreastCancer and #ImmunoOncology